1999
DOI: 10.1089/107999099313523
|View full text |Cite
|
Sign up to set email alerts
|

Lymphocyte Markers and Natural Killer Cell Activity in Fibromyalgia Syndrome: Effects of Low-Dose, Sublingual Use of Human Interferon-alpha

Abstract: A clinical study was designed to utilize flow cytometric immunophenotyping and chromium release from cultured tumor target cells to characterize peripheral blood mononuclear leukocyte (PBML) subpopulations and natural killer activity in healthy normal controls (n = 18) and in patients with fibromyalgia syndrome (FMS) at baseline (n = 124) and again after 6 weeks of treatment with low-doses of orally administered human interferon-alpha (IFN-alpha). Volunteer subjects discontinued all analgesic and sedative hypn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0
1

Year Published

2004
2004
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 37 publications
0
9
0
1
Order By: Relevance
“…93,94 In line with these findings, patients with FM have more activated T-cells circulating in blood compared to healthy controls. 95 Epinephrine activates mast cells and stimulates release of IL-1β, IL-6 and other pro-inflammatory cytokines in a β 2 AR-dependent manner. 44 Increased activation of mast cells has been observed in numerous chronic pain disorders, including FM, headache, vestibulodynia, and irritable bowel syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…93,94 In line with these findings, patients with FM have more activated T-cells circulating in blood compared to healthy controls. 95 Epinephrine activates mast cells and stimulates release of IL-1β, IL-6 and other pro-inflammatory cytokines in a β 2 AR-dependent manner. 44 Increased activation of mast cells has been observed in numerous chronic pain disorders, including FM, headache, vestibulodynia, and irritable bowel syndrome.…”
Section: Discussionmentioning
confidence: 99%
“…The immunological status of individuals suffering from CFS has yielded heterogeneous results [12,17,31,51,52]. Clear examples are data from different CFS cohorts analyzed in a single laboratory [32].…”
Section: Discussionmentioning
confidence: 99%
“…However, in contrast to the L group they had normal levels of CD4 + CD25 low , but increased numbers of CD4 + expressing HLA-DR, a marker of late cellular activation. It is plausible to consider that discrepant data in the literature of CD4 + CD25 low quantification in FM patients [4,8] might be due to different balances of these two genetic groups in those studies, as those studies considered FM patients as a unique homogeneous population [4,8].…”
Section: Discussionmentioning
confidence: 99%